Chiasma, Inc. (NASDAQ:CHMA) Scheduled to Post Earnings on Tuesday
Chiasma, Inc. (NASDAQ:CHMA) will be posting its quarterly earnings results before the market opens on Tuesday, August 8th. Analysts expect Chiasma to post earnings of ($0.23) per share for the quarter.
Chiasma (NASDAQ:CHMA) last released its quarterly earnings results on Friday, May 5th. The biotechnology company reported ($0.29) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.23) by $0.06. On average, analysts expect Chiasma to post $-0.96 EPS for the current fiscal year and $-1.43 EPS for the next fiscal year.
Chiasma, Inc. (NASDAQ:CHMA) opened at 1.45 on Friday. Chiasma, Inc. has a 1-year low of $1.25 and a 1-year high of $3.71. The stock’s market capitalization is $35.32 million. The stock has a 50 day moving average price of $1.43 and a 200-day moving average price of $1.59.
Chiasma Company Profile
Chiasma, Inc is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial of its TPE platform-based product candidate, oral octreotide capsules (trade named as MYCAPSSA) for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone.
Receive News & Ratings for Chiasma Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chiasma Inc. and related companies with MarketBeat.com's FREE daily email newsletter.